Eastman Kodak Co Q4 2022 Earnings Call
We are excited to announce the launch of AlphaStreet Intelligence, a cutting-edge technology driven global ecosystem that ...
Executive Chairman & Chief Executive Officer, Eastman Kodak
Search every verified James Continenza interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. James Continenza, Executive Chairman and CEO of Eastman Kodak, has emphasized the company’s focus on its core businesses of print, film, and chemicals, describing the company as “a chemical company first” and stating that it had “lost its way” before his leadership. He has highlighted efforts to stabilize Kodak’s balance sheet, reduce debt, and improve operational efficiencies, noting that the company reduced net debt by $294 million compared to March 2019. Continenza has also pointed to revenue growth in all segments in 2021 and improvements in gross profit in 2022, attributing these results to cost-cutting, pricing actions, and a strategic plan implemented over the prior four years. In 2020, Continenza announced Kodak’s intention to produce pharmaceutical ingredients, with the U.S. International Development Finance Corporation signing a letter of interest for a potential $765 million loan. He described the loan as repayable over 25 years and said Kodak would repurpose existing buildings at Eastman Business Park to reduce costs. Continenza later stated that the application process had been placed on hold but that Kodak would continue expanding its pharmaceutical business regardless, though the scale and speed would depend on capital availability. He has also discussed investments in digital printing technology, including the release of the Prosper Ultra 520 press, and the construction of a facility to manufacture reagents for health care applications. Continenza has said he is “out” on Kodak’s prior venture into cryptocurrency, stating it is “not what we do.”
We are excited to announce the launch of AlphaStreet Intelligence, a cutting-edge technology driven global ecosystem that ...
Access earnings conference call transcripts at: https://news.alphastreet.com/earnings... Earnings Infographics: https://news.alphastreet.com/infograp... Earnings Calendar: https://news.alphastreet.com/earnings... CEO Interviews: https://news.alphastreet.com/interviews/ Listen on: https://podcasts.apple.com/us/podcast... https://anchor.fm/earningspodcast/ https://open.spotify.com/show/67gyUX6... https://podcasts.google.com/feed/aHR0... https://radiopublic.com/the-earnings-... Follow us on: / alphst_live / _alphastreet / alphastreetinc / alphastreet http://www.google.com/news…
Eastman Kodak Co. Q2 2020 Earnings Conference Call Transcript https://news.alphastreet.com/earnings-call-transcripts/
Access earnings conference call transcripts at: https://news.alphastreet.com/earnings-call-transcripts/ Earnings Calendar: ...
Eastman Kodak made waves on Tuesday with news it is shifting into production of pharmaceutical ingredients with a $765 million ...
Kodak CEO Jim Continenza talks about federal loan to produce key starting materials for drugs.
Eastman Kodak Q4 results fail to impress the street April 1, 2019 Shares of the imaging firm Eastman Kodak (KODK) dropped ...
Sign in to search the full transcript archive, filter by topic, and access every quote from James Continenza.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans